Viewing Study NCT00862992


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2025-12-25 @ 1:45 PM
Study NCT ID: NCT00862992
Status: COMPLETED
Last Update Posted: 2021-04-12
First Post: 2009-03-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
Sponsor: Tanabe Pharma Corporation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04
Start Date Type: None
Primary Completion Date: 2009-09
Primary Completion Date Type: ACTUAL
Completion Date: 2009-09
Completion Date Type: ACTUAL
First Submit Date: 2009-03-15
First Submit QC Date: None
Study First Post Date: 2009-03-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-01-11
Results First Submit QC Date: None
Results First Post Date: 2021-04-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-04-08
Last Update Post Date: 2021-04-12
Last Update Post Date Type: ACTUAL